Table 2.
Treatment parameters for the ten procedures
| Procedure | Dose melphalan (mg) | Duration PHP procedure (h) | Duration of melphalan infusion (min) | Duration of filtration (min) | Location of infusion |
|---|---|---|---|---|---|
| 1 | 220 | 3:58 | NR | 75 | PHA |
| 2 | 180 | 3:26 | 51 | 88 | RHA (144 mg) and LHA (36 mg) |
| 3 | 220 | 3:05 | 50 | 85 | PHA |
| 4 | 220 | 3:28 | 40 | 81 | LHA (180 mg) and RHA (40 mg) |
| 5 | 165 | 3:54 | 40 | 82 | PHA |
| 6 | 210 | 3:59 | 39 | 98 | PHA |
| 7 | 220 | 4:44 | 43 | 79 | RHA (110 mg) and LHA (110 mg) |
| 8 | 220 | 4:45 | 45 | 80 | PHA (110 mg) and RHA (110 mg) |
| 9 | 210 | 3:55 | 40 | 95 | CHA |
| 10 | 220 | 4:15 | 55 | 84 | PHA (110 mg) and replaced RHA(110 mg) |
NR not recorded, PHA proper hepatic artery, RHA right hepatic artery, LHA left hepatic artery, CHA common hepatic artery